These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29771974)

  • 1. Correction: Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    Chen CT; Liu CY; Yu YB; Liu CJ; Hsiao LT; Gau JP; Chiou TJ; Liu JH; Liu YC
    PLoS One; 2018; 13(5):e0197797. PubMed ID: 29771974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe sepsis in hematopoietic stem cell transplant recipients*.
    Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
    Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between costimulatory molecule polymorphism and hepatitis B infections in hematopoietic stem cell transplant recipients.
    Yaghobi R; Saadi MI; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
    Exp Clin Transplant; 2014 Aug; 12(4):357-66. PubMed ID: 24188429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    Chen CT; Liu CY; Yu YB; Liu CJ; Hsiao LT; Gau JP; Chiou TJ; Liu JH; Liu YC
    PLoS One; 2017; 12(9):e0185210. PubMed ID: 28934311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint.
    Solh M; Zhang X; Connor K; Brown S; Morris LE; Holland HK; Bashey A; Solomon SR
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2192-2198. PubMed ID: 28864140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: A mindfulness-based stress management program for caregivers of allogeneic hematopoietic stem cell transplant (HCT) patients: Protocol for a randomized controlled trial.
    Yang MJ; Yepez VV; Brandon KO; Reblin M; Pidala J; Jim HSL; Meyer JS; Gore LR; Khera N; Lau P; Sauls RM; Jones SR; Vinci C
    PLoS One; 2022; 17(9):e0275398. PubMed ID: 36149879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2016 Aug; 12(15):1823-32. PubMed ID: 27168462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Aug; 8(35):60000. PubMed ID: 28938702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.
    Brown RA; Adkins D; Khoury H; Vij R; Goodnough LT; Shenoy S; DiPersio JF
    J Clin Oncol; 1999 Mar; 17(3):806-12. PubMed ID: 10071270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
    Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
    Haematologica; 2016 Nov; 101(11):1417-1425. PubMed ID: 27662016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective.
    Liu YM; Hockenberry M
    J Pediatr Oncol Nurs; 2011; 28(1):6-15. PubMed ID: 20841443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
    Trojan K; Unterrainer C; Weimer R; Bulut N; Morath C; Aly M; Zhu L; Opelz G; Daniel V
    PLoS One; 2017; 12(5):e0179069. PubMed ID: 28562677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HLA Antibody Levels Are Associated With the Risk of Graft Failure After Allogeneic Hematopoietic Stem Cell Transplant.
    Basturk B; Kasar M; Yeral M; Kavuzlu M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):219-223. PubMed ID: 28260472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
    Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
    J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
    Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
    Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of GSTO2 (N142D), GSTT1, and GSTM1 Polymorphisms With Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Khosravi M; Izaddoust M; Saadat I; Karimi MH; Ramzi M
    Exp Clin Transplant; 2016 Aug; 14(4):436-40. PubMed ID: 26103006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.